Scarica l'app Stockscreener
20.77
0.95%
-0.20
Dopo l'orario di chiusura:
20.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$20.97
Aprire:
$20.97
Volume 24 ore:
799.10K
Relative Volume:
0.99
Capitalizzazione di mercato:
$1.53B
Reddito:
$434.49M
Utile/perdita netta:
$504.34M
Rapporto P/E:
3.4537
EPS:
6.0138
Flusso di cassa netto:
$181.97M
1 W Prestazione:
-2.49%
1M Prestazione:
-6.90%
6M Prestazione:
-1.10%
1 anno Prestazione:
+11.49%
Intervallo 1D:
$20.60
$21.16
Intervallo di 1 settimana:
$20.60
$21.95
Portata 52W:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Nome
Innoviva Inc
Settore
Industria
Telefono
(650) 238-9600
Indirizzo
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.77 | 1.57B | 434.49M | 504.34M | 181.97M | 6.0138 |
VRTX
Vertex Pharmaceuticals Inc
|
470.72 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
759.24 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
830.79 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
182.45 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
313.77 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-17 | Iniziato | BTIG Research | Buy |
| 2025-09-30 | Iniziato | Goldman | Sell |
| 2025-08-11 | Iniziato | Oppenheimer | Outperform |
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Iniziato | Goldman | Neutral |
| 2017-11-20 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Innoviva Inc Borsa (INVA) Ultime notizie
Innoviva earnings up next: Can LYNX platform pivot pay off? By Investing.com - Investing.com Australia
Innoviva (INVA): Affordable Growth Stock at a Reasonable Valuation - ChartMill
Innoviva Inc (INVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Innoviva Inc (INVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Innoviva Inc (INVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thai FDA approves Dr Reddy’s gonorrhoea antibiotic - ET Pharma
Innoviva Inc (INVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Innoviva Market Sentiment - Benzinga España
Innoviva Inc (INVA) Balance Sheet - TradingKey
Innoviva, Inc. Revenue Breakdown – MUN:HVE - TradingView
INVA|Innoviva Inc|Price:21.440|Chg%:+0.240 - TradingKey
Innoviva Inc (INVA) Cash Flow - TradingKey
Innoviva, Inc. Revenue Breakdown – DUS:HVE - TradingView
Innoviva Inc (INVA) Income Statement - TradingKey
Innoviva Inc (INVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 66.82% Upside in the Healthcare Sector - DirectorsTalk Interviews
How Innoviva Inc. (INVA) Affects Rotational Strategy Timing - Stock Traders Daily
Innoviva (INVA) Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesEPS Revision Trend - dars.gov.et
Innoviva to Participate in Upcoming Investor Conferences - AOL.com
Innoviva (INVA) Leaves Russell Indexes, Is The Stock Still Cheap? - simplywall.st
Innoviva Inc (NASDAQ:INVA): A Decent Value Play with Strong Fundamentals - ChartMill
Enterprise value to EBITDA forward of Innoviva, Inc. – SWB:HVE - TradingView
Price to sales forward of Innoviva, Inc. – SWB:HVE - TradingView
Innoviva Inc. (INVA) Sees Modest Uptick, Testing Resistance Near $23.43Safe Entry Stocks - dars.gov.et
INVAInnoviva Inc Latest SEC Filings - Finviz
Is Innoviva (INVA) Trading Index Membership for a Deeper Bet on Nortiva Bio’s LYNX Platform? - simplywall.st
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now? - Insider Monkey
5 Cheap Small Cap Stocks to Buy Now - Insider Monkey
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal? - Sahm
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2000 Growth-Defensive Index - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
INVA Forecast — Price Target — Prediction for 2027 - TradingView
How Investors Are Reacting To Innoviva (INVA) Expanding Drug Delivery Tech And XACDURO Global Partnership - Sahm
Enterprise value to EBIT forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
INNOVIVA INC (NASDAQ:INVA): A Strong Growth Stock Poised for a Technical Breakout - ChartMill
Price to earnings forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
(INVA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Price to book forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
Enterprise value to revenue forward of Innoviva, Inc. – GETTEX:HVE - TradingView
Innoviva, Inc. Actuals & Estimates (NASDAQ:INVA) - TradingView
Innoviva, Inc. Actuals & Estimates (DUS:HVE) - TradingView
HVE Forecast — Price Target — Prediction for 2027 - TradingView
Innoviva Inc (INVA) Institutional Confidence - TradingKey
Has Innoviva Successfully Pivoted Beyond its Royalty Roots - Kavout | AI
Price to sales forward of Innoviva, Inc. – GETTEX:HVE - TradingView
Innoviva, Inc. Actuals & Estimates (SWB:HVE) - TradingView
Innoviva, Inc. Actuals & Estimates (LS:A2AC9U) - TradingView
Innoviva Inc Azioni (INVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.84%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):